MedPath
TGA Approval

RIVEXON PATCH 10 rivastigmine 9.5 mg/24 hours transdermal drug delivery system sachet (233750)

233750

RIVEXON PATCH 10 rivastigmine 9.5 mg/24 hours transdermal drug delivery system sachet

Arrotex Pharmaceuticals Pty Ltd

January 12, 2016

Medicine

Medicine

Active

Registered

Active Ingredients

rivastigmine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RIVEXON PATCH 10 rivastigmine 9.5 mg/24 hours transdermal drug delivery system sachet (233750) - TGA 批准文号 | MedPath